The Hedgehog pathway mediator GLI confers a negative prognosis on patients with acute myeloid leukemia and GLI inhibition results in anti-leukemic effects in vitro

被引：0
|
作者：
Wellbrock, J. [1 ]
Latuske, E. [1 ]
Koehler, J. [1 ]
Wagner, K. [2 ]
Stamm, H. [1 ]
Vettorazzi, E. [3 ]
Vohwinkel, G. [1 ]
Klokow, M. [1 ]
Kuehling-Thees, R. [2 ]
Loges, S. [1 ,4 ]
Thol, F. [2 ]
Schubert, C. [5 ]
Amling, M. [6 ]
Juecker, M. [7 ]
Bokemeyer, C. [1 ]
Heuser, M. [2 ]
Krauter, J. [2 ]
Fiedler, W. [1 ]
机构：
[1] Univ Klinikum Hamburg Eppendorf, Hubertus Wald Tumorzentrum, Onkol Hamatol & Knochenmarktransplantat Sekt Pneu, Med Klin & Poliklin 2, Hamburg, Germany
[2] Hannover Med Sch, Klin Hamatol Hamostaseol Onkol & Stammzelltranspl, D-30623 Hannover, Germany
[3] Univ Klinikum Hamburg Eppendorf, Inst Med Biometrie & Epidemiol, Hamburg, Germany
[4] Univ Klinikum Hamburg Eppendorf, Inst Tumorbiol, Hamburg, Germany
[5] Univ Klinikum Hamburg Eppendorf, Inst Transfus Med, Hamburg, Germany
[6] Univ Klinikum Hamburg Eppendorf, Inst Osteol & Biomech, Hamburg, Germany
[7] Univ Klinikum Hamburg Eppendorf, Inst Biochem & Signaltransdukt, Hamburg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V693
引用
收藏
页码：224 / 224
页数：1
相关论文
共 50 条
  • [21] Anti-leukemic effects of simvastatin on NRASG12D mutant acute myeloid leukemia cells
    Jiryeon Jang
    Jeeyun Lee
    Jun Ho Jang
    Chul Won Jung
    Silvia Park
    Molecular Biology Reports, 2019, 46 : 5859 - 5866
  • [22] The Anti-Leukemic Effects of the Pan-Aurora Inhibitor Tozasertib Are Negatively Influenced by Hypoxia in Acute Myeloid Leukemia
    Bruno, Samantha
    Mancini, Manuela
    Monaldi, Cecilia
    De Santis, Sara
    Cavo, Michele
    Soverini, Simona
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S297 - S297
  • [23] The progenitor cell inhibition assay to measure the anti-leukemic reactivity of T cell clones against acute and chronic myeloid leukemia
    van der Hoorn, MAWG
    van Luxemburg-Heijs, SAP
    van Bergen, CAM
    Bongaerts, R
    Willemze, R
    Falkenburg, JHF
    METHODS, 2003, 31 (02) : 113 - 119
  • [24] TARGETED INHIBITION OF MTOR BY AZD8055 BLOCKS PROTEIN TRANSLATION AND HAS ANTI-LEUKEMIC ACTIVITY IN ACUTE MYELOID LEUKEMIA
    Willems, L.
    Chapuis, N.
    Green, A.
    Bardet, V.
    Jacque, N.
    Park, S.
    Ifrah, N.
    Dreyfus, F.
    Guichard, S.
    Mayeux, P.
    Lacombe, C.
    Bouscary, D.
    Tamburini, J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 18 - 18
  • [25] Induction of in vitro anti-leukemic response by autologous dendritic cells loaded with eluted peptides from acute myeloid leukemia cells
    Delluc, S
    Connan, F
    Boix, C
    Choppin, J
    Guillet, J
    Buzyn, A
    BONE MARROW TRANSPLANTATION, 2003, 31 : S203 - S203
  • [26] Anti-leukemic activity of Cyperus rotundus L.on human acute myeloid leukemia HL-60 cells in vitro
    Agustini, Sulistyo Mulyo
    Widjajanto, Edi
    Rifa'i, Muhaimin
    Haryana, Sofia Mubarika
    Nurdiana
    Lyrawati, Diana
    Sukorini, Usi
    Lestari, Noviana Dwi
    JOURNAL OF PHARMACY & PHARMACOGNOSY RESEARCH, 2023, 11 (01): : 191 - 197
  • [27] T cells are required for the CMV-induced anti-leukemic effect in patients with acute myeloid leukemia patients after transplant
    Elmaagacli, A. H.
    Koldehoff, M.
    Sonius, M.
    Steckel, N. K.
    Trenschel, R.
    Ditschkowski, M.
    Gromke, T.
    Ross, R. S.
    Ottinger, H.
    Beelen, D.
    ONKOLOGIE, 2012, 35 : 173 - 173
  • [28] In Vitro and In Vivo Anti-Leukemic Effects of KPT-9274, a Reported PAK4 Allosteric Modulator, in Acute Myeloid Leukemia: Promising Results Justifying Further Development in This Disease
    Mitchell, Shaneice
    Orwick, Shelley
    Cannon, Matthew
    Goettl, Virginia M.
    LaFollette, Taylor D.
    Baloglu, Erkan
    Senapedis, William
    Walker, Alison R.
    Bhatnagar, Bhavana
    Mims, Alice S.
    Klisovic, Rebecca B.
    Vasu, Sumithira
    Blum, William
    Lucas, David M.
    Blachly, James S.
    Garzon, Ramiro
    Bloomfield, Clara D.
    Lapalombella, Rosa
    Byrd, John C.
    BLOOD, 2015, 126 (23)
  • [29] Expression of Roundabout Receptor 4 (Robo-4) Confers a Negative Prognosis On Patients with Acute Myeloid Leukemia
    Wellbrock, Jasmin
    Vettorazzi, Eik
    Vohwinkel, Gabi
    Mueller, Thoren
    Klokow, Marianne
    Bokemeyer, Carsten
    Bacher, Ulrike
    Krauter, Juergen
    Fiedler, Walter
    BLOOD, 2012, 120 (21)
  • [30] PARP Inhibition with Talazoparib Enhances DNA Damage and Anti-Leukemic Activity of Venetoclax in Preclinical Human Acute Myeloid Leukemia (AML) Models
    Giorgi, Marianna
    Portwood, Scott M.
    Boncek, Marina
    Wang, Eunice S.
    BLOOD, 2021, 138
12345